您的位置: 首页 > 农业专利 > 详情页

藥物組合
专利权人:
Novartis AG
发明人:
Dale PORTER,Caroline EMERY,Lujian TAN,Padmaja YERRAMILLI-RAO
申请号:
HK16103725.8
公开号:
HK1215789A
申请日:
2016.03.31
申请国别(地区):
HK
年份:
2016
代理人:
摘要:
A pharmaceutical combination comprising (a) a protein kinase C (PKC) inhibitor compound, or a pharmaceutically acceptable salt thereof, and (b) at least one mitogen activated protein kinase (MEK) inhibitor or a pharmaceutically acceptable salt, and optionally a pharmaceutically acceptable carrier, for simultaneous, separate or sequential administration; the uses of such combination in the treatment of proliferative diseases; and methods of treating a subject suffering from a proliferative disease comprising administering a therapeutically effective amount of such combination.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充